Modulation of Macrophage Polarization by Traditional Chinese Medicine in HFpEF: A Review of Mechanisms and Therapeutic Potentials
Open Access
- 2 September 2025
- journal article
- review article
- Published by MDPI AG in Pharmaceuticals
- Vol. 18 (9) , 1317
Abstract
Heart failure with preserved ejection fraction (HFpEF) is a multifactorial cardiovascular disorder characterized by diastolic dysfunction, systemic inflammation, and myocardial fibrosis. Emerging evidence indicates that macrophage polarization imbalance plays a central role in HFpEF pathogenesis. Traditional Chinese medicine (TCM) has demonstrated therapeutic potential in modulating macrophage activity through pathways such as NO/cGMP/PKG, TGF-β/Smads, and PI3K/Akt, thereby exerting anti-inflammatory, antifibrotic, and antioxidant effects. In this review, we conducted a literature search in PubMed, Google Scholar, Web of Science, and CNKI for studies published up to May 2025, using the terms “HFpEF”, “Traditional Chinese Medicine”, and “macrophage”. A total of 19 relevant studies were included. We highlight representative TCM metabolites and TCM formulas, such as resveratrol, Qishen Yiqi Pill, Shenfu Injection, etc. And we summarize their mechanisms in regulating M1/M2 macrophage polarization. Finally, we identify current challenges, including limited HFpEF-specific models and insufficient mechanistic validation, and propose directions for future research.Keywords
Funding Information
- Three-year Action Plan of the Major Clinical Research Program of Shanghai Shenkang Medical Development Center (SHDC2020CR1053B, 82274306, 81973656, SHDC12018125, 18401932800, SGGZS-202236, 2024Aa10040)
- National Natural Science Foundation of China (SHDC2020CR1053B, 82274306, 81973656, SHDC12018125, 18401932800, SGGZS-202236, 2024Aa10040)
- Shanghai Shenkang Medical Development Center Emerging Frontier Technology Joint Research Project (SHDC2020CR1053B, 82274306, 81973656, SHDC12018125, 18401932800, SGGZS-202236, 2024Aa10040)
- science and technology support project of the Shanghai Science and technology commission (SHDC2020CR1053B, 82274306, 81973656, SHDC12018125, 18401932800, SGGZS-202236, 2024Aa10040)
- Construction Project for Well-known Elderly TCM Specialist Academic Experience Research of Shanghai (SHDC2020CR1053B, 82274306, 81973656, SHDC12018125, 18401932800, SGGZS-202236, 2024Aa10040)
- nhui Provincial Health Research Program (SHDC2020CR1053B, 82274306, 81973656, SHDC12018125, 18401932800, SGGZS-202236, 2024Aa10040)
This publication has 191 references indexed in Scilit:
- Transcutaneous Auricular Vagus Nerve Stimulation Ameliorates Heart Failure with Preserved Ejection Fraction Through Regulating Macrophage Polarization Mediated by Alpha7nAChRCardiovascular Drugs and Therapy, 2025
- VASP Knockdown Ameliorates Lipopolysaccharide-Induced Acute Lung Injury with Inhibition of M1 Macrophage Polarization Through the cGMP-PKG Signaling PathwayInflammation, 2025
- Oxygen‐Independent Photodynamic Therapy‐Mediated Selective Consumption of M1 Macrophage Against Ventricular Arrhythmias via Sympathetic NeuromodulationSmall, 2024
- Single-cell transcriptomics reveal distinctive patterns of fibroblast activation in heart failure with preserved ejection fractionBasic Research in Cardiology, 2024
- Corynoline protects chronic pancreatitis via binding to PSMA2 and alleviating pancreatic fibrosisJournal of Gastroenterology, 2024
- Atrial Fibrillation Ablation in Heart Failure With Reduced vs Preserved Ejection FractionJAMA Cardiology, 2024
- Genetically Engineered Macrophages Co‐Loaded with CD47 Inhibitors Synergistically Reconstruct Efferocytosis and Improve Cardiac Remodeling Post Myocardial Ischemia Reperfusion InjuryAdvanced Healthcare Materials, 2024
- Macrophage profiling in atherosclerosis: understanding the unstable plaqueBasic Research in Cardiology, 2024
- Heart Failure With Preserved Ejection FractionJAMA, 2023
- Multiple roles of cardiac macrophages in heart homeostasis and failureHeart Failure Reviews, 2021